68Ga-DOTANOC PET/CT Clinical Impact in Patients with Neuroendocrine Tumors-Reference-Cited by-同舟云学术

68Ga-DOTANOC PET/CT Clinical Impact in Patients with Neuroendocrine Tumors

Published:2010-04-15 Issue:5 Volume:51 Page:669-673
ISSN:0161-5505
Container-title:Journal of Nuclear Medicine
language:en
Short-container-title:J Nucl Med

Author:

Ambrosini Valentina,Campana Davide,Bodei Lisa,Nanni Cristina,Castellucci Paolo,Allegri Vincenzo,Montini Gian Carlo,Tomassetti Paola,Paganelli Giovanni,Fanti Stefano

Publisher

Society of Nuclear Medicine

Subject

Radiology, Nuclear Medicine and imaging

Reference29 articles.

1. Nuclear imaging of neuroendocrine tumours

2. Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours

3. Are radiogallium-labelled DOTA-conjugated somatostatin analogues superior to those labelled with other radiometals?

4. 68Ga-DOTANOC: biodistribution and dosimetry in patients affected by neuroendocrine tumors

5. Recent advances in radiological and radionuclide imaging and therapy of neuroendocrine tumours

Cited by 219 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dual Somatostatin Receptor/¹⁸F-FDG PET/CT Imaging in Patients with Well-Differentiated, Grade 2 and 3 Gastroenteropancreatic Neuroendocrine Tumors;Journal of Nuclear Medicine;2024-09-12

2. Various Markers of Neuroendocrine Tumor: A Narrative Review;Cureus;2024-08-22

3. Innovative radiopharmaceuticals in cancer diagnostics and radionuclide therapy;Вестник Российской академии наук;2024-07-04

4. State-of-the-Art Hybrid Imaging of Neuroendocrine Neoplasms;Journal of Computer Assisted Tomography;2024-04-11

5. Liver Imaging in Gastroenteropancreatic Neuroendocrine Neoplasms;Journal of Computer Assisted Tomography;2024-02-27